Doctor’s aptitude for switching from innovator etanercept to biosimilar etanercept in inflammatory rheumatic diseases: experience from a single French rheumatology tertiary care center

被引：0
|
作者：
Omar Al Tabaa
Adrien Etcheto
Sophie Dumas
Frederic Batteux
Claire Goulvestre
Anna Moltó
Corinne Miceli-Richard
Maxime Dougados
机构：
[1] Paris Descartes University,Department of Rheumatology
[2] Paris University, Hôpital Cochin. Assistance Publique
[3] Cochin Hospital, Hôpitaux de Paris, EULAR center of excellence
[4] AP-HP,Department of Pharmacy
[5] Cochin Hospital,Department of Immunology
[6] AP-HP,Sorbonne Paris
[7] Paris Descartes University,Cité, INSERM U1016, Cochin Institute, CARPEM
[8] Paris University,INSERM (U1153): Clinical Epidemiology and Biostatistics
[9] PRES Sorbonne Paris-Cité,Immunoregulation Unit, Unité Mixte AP
[10] Institut Pasteur,HP/Institut Pasteur
来源：
European Journal of Clinical Pharmacology | 2021年 / 77卷
关键词：
Etanercept; SB4; Biosimilar; Switch; Rheumatoid arthritis; Spondyloarthritis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：25 / 33
页数：8
相关论文
共 23 条
  • [1] Doctor's aptitude for switching from innovator etanercept to biosimilar etanercept in inflammatory rheumatic diseases: experience from a single French rheumatology tertiary care center
    Al Tabaa, Omar
    Etcheto, Adrien
    Dumas, Sophie
    Batteux, Frederic
    Goulvestre, Claire
    Molto, Anna
    Miceli-Richard, Corinne
    Dougados, Maxime
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 77 (01) : 25 - 33
  • [2] SWITCH FROM INNOVATOR ETANERCEPT TO BIOSIMILAR ETANERCEPT IN INFLAMMATORY RHEUMATIC DISEASES: THE EXPERIENCE OF COCHIN UNIVERSITY HOSPITAL PARIS-FRANCE.
    Al Tabaa, O.
    Etcheto, A.
    Miceli-Richard, C.
    Anna, M.
    Dougados, M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 960 - 960
  • [3] SWITCHING FROM ETANERCEPT ORIGINAL TO ETANERCEPT BIOSIMILAR. EXPERIENCE IN A TERTIARY HOSPITAL.
    Aldasoro, V.
    Mendizabal, J.
    Perez Garcia, S.
    Sada Urmeneta, G.
    Restrepo Velez, J.
    Del Val Del Amo, N.
    Paniagua Zudaire, I.
    Gutierrez Polo, R.
    Horcada, L.
    Garrido Courel, L.
    Fito-Manteca, C.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1430 - 1431
  • [4] SWITCHING FROM ENBREL TO ETANERCEPT BIOSIMILAR (BENEPALI). EXPERIENCE IN TWO TERTIARY HOSPITALS
    Aldasoro Caceres, Vicente
    Lamua Riazuelo, Jose Ramon
    Mendizabal Mateo, Javier
    Perez Gacia, Sara
    Sada Urmeneta, Guillen
    Restrepo Velez, Juliana
    Garrido Courel, Laura
    Gutierrez Polo, Ricardo
    Paniagua Zudaire, Inmaculada
    del Val del Amo, Natividad
    Horcada Rubio, Loreto
    Fito Manteca, Concepcion
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2020, 26 : 69 - 70
  • [5] RESULTS OF A MANDATORY SWITCHING FROM ORIGINATOR TO BIOSIMILAR ETANERCEPT IN 117 PATIENTS WITH INFLAMMATORY ARTHRITIS FROM A SINGLE CENTER
    Fernandez, Sabela
    Gonzalez, Senen
    Ordas-Calvo, Carmen
    Garcia-Fernandez, Edilia
    Rodriguez-De-Castro, Belen
    Babio, Jesus
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1648 - 1648
  • [6] IMPACT OF BLOCK SWITCH TO BIOSIMILAR ETANERCEPT IN PRACTICE - AN EXPERIENCE FROM ONE TERTIARY RHEUMATOLOGY DEPARTMENT
    Brites, Luisa
    Costa, Flavio
    de Freitas, Joao Dinis
    Luis, Mariana
    Coutinho, Margarida
    Santiago, Mariana
    Salvador, Maria Joao
    Duarte, Catia
    Jose Antonio Da Silva, P.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1372 - 1372
  • [7] SWITCHING OF TREATMENT FROM REFERENCE ETANERCEPT TO SANDOZ ETANERCEPT BIOSIMILAR IN PATIENTS WITH RHEUMATIC DISEASES: AN INTERIM ANALYSIS OF REAL-WORLD DATA FROM THE COMPACT STUDY
    Schmalzing, M.
    Askari, A.
    Sheeran, T.
    Walsh, D.
    De Toro Santos, J.
    Vazquez Perez-Coleman, J. C.
    Both, C.
    Furlan, F.
    Hachaichi, S.
    Kellner, H.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 540 - 540
  • [8] SAFETY AND RETENTION RATE AFTER SWITCHING FROM ETANERCEPT ORIGINATOR (ETN) TO ETANERCEPT BIOSIMILAR (SB4) IN INFLAMMATORY JOINT DISEASES: DATA FROM REAL LIFE.
    Bruni, C.
    Gentileschi, S.
    Capassoni, M.
    Pacini, G.
    Bardelli, M.
    Baldi, C.
    Tofani, L.
    Cometi, L.
    Nacci, F.
    Bartoli, F.
    Fiori, G.
    Cantarini, L.
    Guiducci, S.
    Frediani, B.
    Matucci-Cerinic, M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1435 - 1436
  • [9] Switching Patients with Arthritis from Etanercept (Enbrel) to the Biosimilar Drug, Benepali: A Single- Center Retrospective Observational Study
    Madenidou, Anastasia-Vasiliki
    Jeffries, Andrew
    Varughese, Sneha
    Jones, Stephen
    Veevers, Helen
    Sari-Kouzel, Hanadi
    Rao, Chandini
    [J]. ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [10] Effects of non-medical infliximab biosimilar switching in ocular inflammatory diseases: A case series from a tertiary care center
    Dolinko, Andrew H.
    Morvey, Diana Edem
    Apoorva, Shimy
    Chikovsky, Max
    Anesi, Stephen D.
    Foster, C. Stephen
    [J]. EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2024, 34 (03) : 774 - 780
123